TCMBANKIN007874 |
sargencuneside |
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(3-methoxy-4-methylphenoxy)oxane-3,4,5-triol; AC1NT08F |
|
|
CC1=C(C=C(C=C1)OC2C(C(C(C(O2)CO)O)O)O)OC |
TCMBANKIN011905 |
pachysamine b |
|
C29H50N2O |
442.7 g/mol |
CC(C1CCC2C1(CCC3C2CCC4C3(CCC(C4)N(C)C(=O)C=C(C)C)C)C)N(C)C |
TCMBANKIN033505 |
pachysamine a |
|
C24H44N2 |
360.6 g/mol |
CC(C1CCC2C1(CCC3C2CCC4C3(CCC(C4)NC)C)C)N(C)C |
TCMBANKIN038177 |
sarcovagine a |
|
C28H48N2O3 |
|
|
TCMBANKIN046243 |
Sarcovagine B |
|
|
|
|
TCMBANKIN049569 |
Sarcovaging B |
|
C30H50N2O4 |
|
[C@]1([H])(O[H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(N(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C2([H])[H])[C@]23
[H])[C@@]3([H])C([H])([H])C4([H])[H])[C@]4([H])[C@@]([H])(OC(C([H])([H])[H])=O)[C@@]1([H])N(C(=O)\C(\C([H])([H])[H])=C(\C([H])([H])[H])[H])[H] |
TCMBANKIN059371 |
sarcovaging d |
sarcovaging d |
C28H44N2O2 |
440.7 g/mol |
CC=C(C)C(=O)NC1=CCC2(C3CCC4(C(C3CCC2C1=O)CCC4C(C)N(C)C)C)C |
TCMBANKIN059372 |
sarcovagine c |
|
C30H50N2O3 |
|
CC=C(C)C(=O)NC1CCC2(C(C1OC(=O)C)CCC3C2CCC4(C3CCC4C(C)N(C)C)C)C |